[1]
Є. А. Квятковський and Т. О. Квятковська, “The prediction of silodosin expected effectiveness in the lower urinary tract symptoms treatment with benign prostatic hyperplasia patients”, HM, no. 1(60), pp. 91–94, Mar. 2017.